Join to View Full Profile
18433 Roscoe Blvd#208Northridge, CA 91325
Phone+1 818-341-4401
Fax+1 818-341-4402
Dr. Chow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christopher Chow, based in Northridge, CA, specializes in Internal Medicine. He completed his residency in Internal Medicine at Cedars-Sinai Medical Center from 1999 to 2002, after graduating from New York Medical College in 1999. He is a participant in the clinical trial of Tirzepatide (LY3298176) for Type 2 Diabetes Mellitus. He was honored with the CMS Meaningful Use Stage 1 Certification from athenaClinicals EHR, athenahealth, Inc in 2012-2013.
Education & Training
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1999 - 2002
New York Medical CollegeClass of 1999
Certifications & Licensure
CA State Medical License 2000 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
Clinical Trials
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
